| Product NDC: | 0555-0877 |
| Proprietary Name: | Fluoxetine |
| Non Proprietary Name: | Fluoxetine hydrochloride |
| Active Ingredient(s): | 20 mg/1 & nbsp; Fluoxetine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0555-0877 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074803 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010802 |
| Package NDC: | 0555-0877-07 |
| Package Description: | 2000 CAPSULE in 1 BOTTLE (0555-0877-07) |
| NDC Code | 0555-0877-07 |
| Proprietary Name | Fluoxetine |
| Package Description | 2000 CAPSULE in 1 BOTTLE (0555-0877-07) |
| Product NDC | 0555-0877 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluoxetine hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20010802 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | FLUOXETINE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |